Almost every compound in our peptide series carries the same asterisk: interesting early science, no approved product, no legal pathway for human use. Human growth hormone is the exception that proves the rule. HGH — prescribed as somatropin — is a fully registered medicine in Australia, subsidised on the PBS for specific conditions, prescribed by specialists and manufactured to pharmaceutical standards. It is also one of the most hyped substances in the anti-aging and bodybuilding world, where the evidence tells a far less flattering story. Both things are true at once, and the gap between them is the most instructive thing about it.
What growth hormone actually is
Growth hormone is a 191-amino-acid peptide hormone made by the pituitary gland. In childhood it drives linear growth; across life it helps regulate body composition, bone and metabolism, working largely by prompting the liver to produce insulin-like growth factor 1 (IGF-1). People whose pituitary makes too little of it — because of a congenital condition, a tumour, surgery or radiotherapy — have a genuine, measurable deficiency that replacement corrects.
The pharmaceutical version, somatropin, is recombinant human growth hormone: identical to the natural molecule, produced in engineered cells since the mid-1980s. Familiar brands include Genotropin and Norditropin, and newer once-weekly analogues — somatrogon and somapacitan — are registered too. Four decades of clinical use, formal trials and pharmacovigilance: this is what an established medicine looks like.
HGH in Australia: TGA approval, PBS subsidy — and the law
In Australia, somatropin is a Schedule 4 (Prescription Only) medicine under the Poisons Standard, registered with the TGA for defined indications. Subsidised access runs through the PBS Growth Hormone Program, a Section 100 programme with restriction criteria the PBS itself describes as "clinically complex". Prescribers apply to Services Australia for authority, and treatment is anchored to specialist care — typically a paediatric endocrinologist for children or an endocrinologist for adults.
The paediatric categories give a sense of how targeted the programme is: short stature with biochemically proven growth hormone deficiency, short stature associated with Turner syndrome, SHOX gene disorders, chronic renal insufficiency, Prader-Willi syndrome, growth retardation secondary to an intracranial lesion or cranial irradiation, and neonates at risk of hypoglycaemia from growth hormone deficiency. Adults with severe, properly diagnosed growth hormone deficiency are covered under separate criteria. Height percentiles, growth velocity and stimulation testing are all part of the assessment — nobody is waved through.
There is no "wellness" pathway. Outside a valid prescription, possessing or supplying HGH is illegal under state and territory medicines law. It is also border-controlled: growth hormone requires an import permit from the Office of Drug Control and is excluded from the TGA's Personal Importation Scheme — the scheme that otherwise lets travellers and patients bring in up to three months' supply of prescription medicines. Unpermitted parcels are seized by the Australian Border Force. Ordering HGH from an overseas website is a customs offence, not a grey area.
| Prescribed somatropin | Non-prescribed HGH | |
|---|---|---|
| Legal status | Schedule 4, TGA-registered, PBS-subsidised if eligible | Illegal to possess or supply; imports without a permit are seized |
| Product | Known brands, batch-tested, cold-chain | Unverified vials; counterfeits and underdosing are common |
| Oversight | Specialist monitoring of IGF-1, glucose, growth | None |
| Evidence | Clear benefit in diagnosed deficiency | Modest body-composition change, real side effects |
| Sport | Still WADA-prohibited | WADA-prohibited at all times |
The anti-aging story the evidence doesn't support
The hype has a precise origin: a 1990 New England Journal of Medicine study by Daniel Rudman, in which twelve men over 60 given growth hormone for six months gained lean mass and lost fat. It was small, short and measured no functional outcomes — but it launched an industry of "HGH anti-aging" clinics almost overnight.
The follow-up science is much less exciting. A 2007 systematic review in the Annals of Internal Medicine pooled the randomised trials of growth hormone in healthy older adults. The result: lean body mass up by about 2.1 kg, fat down by roughly the same — and no improvement in bone density, cholesterol or maximal oxygen uptake. What participants did get was soft-tissue swelling (oedema), joint pain, carpal tunnel syndrome and a trend toward new diagnoses of diabetes and impaired fasting glucose. The authors' conclusion was blunt: growth hormone "cannot be recommended as an anti-aging therapy". A companion review in athletes found no meaningful gain in strength or exercise capacity either — part of the added "lean mass" appears to be retained fluid, not contractile muscle.
That is the honest trade on offer: a modest change in body composition, purchased with insulin resistance, swollen joints and numb hands. And for anyone in organised sport, growth hormone sits in section S2 of the WADA Prohibited List — peptide hormones and growth factors — banned at all times, in and out of competition, along with the releasing peptides and secretagogues sold as workarounds.
The risks are not theoretical
Chronic growth hormone excess produces a well-described disease: acromegaly. As Australia's healthdirect puts it, using growth hormone without a prescription can cause serious health problems, including excessive bone growth, diabetes, high blood pressure and heart problems. The metabolic harm is mechanistic — growth hormone directly opposes insulin's action, which is why glucose is monitored even in legitimate therapy. Black-market use adds a second layer of risk that has nothing to do with the molecule: counterfeit or underdosed vials, no cold chain, contamination — the same supply problems as any unregulated injectable.
What HGH tells you about "research peptides"
Set HGH beside the unapproved compounds covered elsewhere on our peptides hub and the contrast is the whole lesson. HGH is what the finish line of drug development looks like: decades of trials, registration, defined indications, subsidy, specialist monitoring. Yet even with all of that evidence behind it, it is approved only for diagnosed deficiency and specific growth disorders — not for aging, not for physique. No sponsor has ever taken those uses through a regulator, because the trials that exist don't support them.
Keep that in mind when a compound with zero approved products anywhere on earth is described online as safe and effective. If four decades of data earn HGH only a narrow approval, marketing copy is not going to close that gap for anything else. Our HGH profile covers the pharmacology, dosing forms and trial history in more depth.
Where that leaves you
If you're worried about your child's growth, or about symptoms that might reflect genuine deficiency, the path is unglamorous but real: GP, referral, endocrinologist, testing — and if criteria are met, PBS-subsidised treatment. For everyone else, the evidence says the anti-aging promise is mostly water weight and wishful thinking, and Australian law leaves no legal way to experiment outside that clinical pathway anyway.
We track the clinical and regulatory landscape for peptides and metabolic medicines in Australia as it moves — join the free update list to get new evidence-first analyses as they publish.
FAQ
Is HGH legal in Australia?
Only with a prescription. Somatropin is a Schedule 4 prescription-only medicine, so possessing or supplying it without a prescription is illegal. It is also border-controlled: importing growth hormone requires a permit from the Office of Drug Control, it is excluded from the TGA's Personal Importation Scheme, and unpermitted parcels are seized.
Does HGH reverse aging?
No. A systematic review of trials in healthy older adults found about 2 kg of lean mass gained and a similar amount of fat lost, with no improvement in bone density, cholesterol or fitness — but more oedema, joint pain, carpal tunnel syndrome and a trend toward diabetes. The authors concluded it cannot be recommended as an anti-aging therapy.
Is HGH covered by the PBS?
Yes, for eligible patients under the PBS Growth Hormone Program — including children with proven growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, chronic renal insufficiency or SHOX disorders, and adults with severe growth hormone deficiency. Criteria are strict and applications go through Services Australia with specialist involvement.
Is HGH banned in sport?
Yes. Growth hormone sits in section S2 of the WADA Prohibited List and is banned at all times, in and out of competition — as are growth hormone releasing peptides and secretagogues.
Sources
- Human growth hormone — healthdirect (Australian Government)
- PBS Growth Hormone Program — Pharmaceutical Benefits Scheme
- Liu H, et al. Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly. Annals of Internal Medicine, 2007
- Importing a medicine or medical device — Therapeutic Goods Administration
This article is general information, not medical advice — speak to your doctor about anything affecting your health. retatrutide.net.au is independent and not affiliated with any pharmaceutical company or seller.